Ukrainian Health Ministry to include Bioven in COVID-19 treatment protocol
"We have completed clinical trials. There are relevant reports. Immunoglobulins have shown themselves well. The drug Bioven is a drug of Ukrainian origin that is used in our country. A respective working group dealing with the protocols will be gathered. [...] Yesterday, in a preliminary conversation with them, they said they planned to include this drug in the treatment protocol. As it is expensive, we have found a source from which we will finance and purchase this drug so that it was delivered to our hospitals," Stepanov said at a briefing on Wednesday, October 7.
He added that the drug Remdesivir, which has shown good results in the treatment of patients with COVID-19 abroad, is to be delivered to Ukraine.
Some 239,337 cases of COVID-19 were recorded in Ukraine as of October 7. A record 4,753 new coronavirus cases have been registered in Ukraine in the past 24 hours.
op